There is an urgent need for precision immunotherapy strategies that simultaneously target both tumor cells and immune cells ...

A bold funding initiative aims to help scientists predict a T cell’s target antigens, with implications far beyond cancer ...

A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved ...

When your social media account starts spewing out nonsensical or threatening status updates, it's safe to assume that it has ...

A new article outlines a new tool that measures blood inflammation as a marker for poor CAR T therapy outcomes.

According to a recent study, researchers are developing nanotechnology that can improve the treatment of one of the most ...

The addition of nivolumab to neoadjuvant chemotherapy significantly increased pathologic complete response among certain patients with breast cancer, according to findings published in Nature Medicine ...

T cell engagers are an exciting area of immunotherapy that remains in the early innings of development. We believe gamma-delta T cells offer unique properties, including tissue residence, phagocytosis ...

Immunotherapy is a type of cancer treatment that helps your immune system detect and fight cancer cells. Treatments may be administered via a catheter, intravenously, or by injection. There are ...

Adjuvant camrelizumab significantly improves event-free survival in patients with locoregionally advanced nasopharyngeal ...

Parker Institute for Cancer Immunotherapy has named Karen E. Knudsen, MBA, PhD, as its new CEO, according to a press ...

The Parker Institute for Cancer Immunotherapy (PICI) today announced the appointment of Karen E. Knudsen, MBA PhD as its new ...